Achira is engaged in development and commercialisation of point of care (PoC) medical test kits in India.
Cipla has signed definitive agreements for further investment of up to Rs 26 crore (approx.) in Optionally Convertible Preference Shares of Achira Labs , in four tranches, subject to completion of certain milestones.
Achira is engaged in development and commercialisation of point of care (PoC) medical test kits in India.
Pursuant to the completion of the first tranche of investment, Cipla shall hold 27.27 per cent of the total voting rights in Achira.